C3ORF10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.998600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.841800E-01
Normal-vs-Stage2
7.435200E-01
Normal-vs-Stage3
4.710600E-01
Normal-vs-Stage4
1.761230E-01
Stage1-vs-Stage2
6.247600E-01
Stage1-vs-Stage3
3.823600E-01
Stage1-vs-Stage4
3.136600E-01
Stage2-vs-Stage3
3.044600E-01
Stage2-vs-Stage4
1.085010E-01
Stage3-vs-Stage4
1.725830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.482400E-01
Normal-vs-AfricanAmerican
5.596400E-01
Normal-vs-Asian
3.324400E-01
Caucasian-vs-AfricanAmerican
5.443000E-01
Caucasian-vs-Asian
3.087800E-01
AfricanAmerican-vs-Asian
8.745000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.712000E-01
Normal-vs-Female
8.357600E-01
Male-vs-Female
6.417000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.286400E-01
Normal-vs-Age(41-60Yrs)
8.691800E-01
Normal-vs-Age(61-80Yrs)
6.105800E-01
Normal-vs-Age(81-100Yrs)
5.823400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.894800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.277400E-03
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.018500E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.693940E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.721810E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.945000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.851800E-01
Normal-vs-Daily Drinker
8.472200E-01
Normal-vs-Weekly Drinker
3.488600E-01
Normal-vs-Occasional Drinker
7.010800E-01
Normal-vs-Social Drinker
4.365800E-01
Non Drinker-vs-Daily Drinker
8.242400E-01
Non Drinker-vs-Weekly Drinker
4.551200E-01
Non Drinker-vs-Occasional Drinker
2.055400E-01
Non Drinker-vs-Social Drinker
6.294000E-01
Daily Drinker-vs-Weekly Drinker
3.708200E-01
Daily Drinker-vs-Occasional Drinker
2.770400E-01
Daily Drinker-vs-Social Drinker
5.028000E-01
Weekly Drinker-vs-Occasional Drinker
5.082000E-02
Weekly Drinker-vs-Social Drinker
7.505600E-01
Occasional Drinker-vs-Social Drinker
7.464300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.101800E-01
Normal-vs-Grade 2
7.967600E-01
Normal-vs-Grade 3
8.117200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.871700E-02
Grade 1-vs-Grade 3
1.721220E-01
Grade 1-vs-Grade 4
9.101800E-01
Grade 2-vs-Grade 3
7.431000E-01
Grade 2-vs-Grade 4
7.967600E-01
Grade 3-vs-Grade 4
8.117200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.037200E-01
Normal-vs-NonDiabetic
8.082600E-01
Diabetic-vs-NonDiabetic
8.416600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.599800E-01
Normal-vs-NoPancreatitis
7.941200E-01
Pancreatitis-vs-NoPancreatitis
2.535000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.348600E-01
Normal-vs-N1
7.777200E-01
N0-vs-N1
4.894400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.721200E-01
Normal-vs-TP53-NonMutant
4.594400E-01
TP53-Mutant-vs-TP53-NonMutant
3.063500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
